Furthermore, Rif1 may act as an anti-checkpoint shield in repairing defective double-strand breaks (DSB) of DNA in breast cancer, and inhibition of its expression sensitizes cancer cells to drugs [42,43]. Here, RIF1 is linked to breast cancer.